Cost-effectiveness of early responders versus early nonresponders to atypical antipsychotic therapy
Xiaomei Peng1, Haya Ascher-Svanum1, Douglas E Faries1, Virginia L Stauffer1, Sara Kollack-Walker1, Bruce J Kinon1, John M Kane21Eli Lilly and Company, Indianapolis, Indiana; 2Zucker Hillside Hospital, Department of Psychiatry, Glen Oaks, New York, USABackground: To compare the cost-effectiveness of...
Main Authors: | Peng X, Ascher-Svanum H, Faries DE, Stauffer VL, Kollack-Walker S, Kinon BJ, Kane JM |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-04-01
|
Series: | ClinicoEconomics and Outcomes Research |
Online Access: | http://www.dovepress.com/cost-effectiveness-of-early-responders-versus-early-nonresponders-to-a-a7197 |
Similar Items
-
Identification of early changes in specific symptoms that predict longer-term response to atypical antipsychotics in the treatment of patients with schizophrenia
by: Ascher-Svanum Haya, et al.
Published: (2011-02-01) -
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
by: Correll Christoph, et al.
Published: (2005-05-01) -
Comparison of patients undergoing switching versus augmentation of antipsychotic medications during treatment for schizophrenia
by: Ascher-Svanum H, et al.
Published: (2012-03-01) -
Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia
by: Swartz Marvin, et al.
Published: (2006-02-01) -
Predictors of switching antipsychotic medications in the treatment of schizophrenia
by: Stauffer Virginia L, et al.
Published: (2010-09-01)